![What is new in lipid‐lowering therapies in diabetes? - Cheung - 2019 - Internal Medicine Journal - Wiley Online Library What is new in lipid‐lowering therapies in diabetes? - Cheung - 2019 - Internal Medicine Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffcfac88-008a-4886-873e-62e3c1bccc9d/imj14291-fig-0001-m.jpg)
What is new in lipid‐lowering therapies in diabetes? - Cheung - 2019 - Internal Medicine Journal - Wiley Online Library
![New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 | Journal of the American College of Cardiology New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/35e850a4-f7b1-4592-b0cc-53bb4e87a9c0/fx1.jpg)
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 | Journal of the American College of Cardiology
![Statins: a viable candidate for host-directed therapy against infectious diseases | Nature Reviews Immunology Statins: a viable candidate for host-directed therapy against infectious diseases | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41577-018-0094-3/MediaObjects/41577_2018_94_Fig1_HTML.png)
Statins: a viable candidate for host-directed therapy against infectious diseases | Nature Reviews Immunology
![Table 3 from Cardiovascular risk reduction: the future of cholesterol lowering drugs. | Semantic Scholar Table 3 from Cardiovascular risk reduction: the future of cholesterol lowering drugs. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be79d25eae29a4959a66680e2f49a2b29c1c7dfb/4-Table3-1.png)
Table 3 from Cardiovascular risk reduction: the future of cholesterol lowering drugs. | Semantic Scholar
![IJMS | Free Full-Text | Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges IJMS | Free Full-Text | Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges](https://pub.mdpi-res.com/ijms/ijms-24-03291/article_deploy/html/images/ijms-24-03291-g002.png?1675909673)